Menü
Microsoft selbst warnt vor der Verwendung von Internet Explorer, da er nicht mehr den neuesten Web- und Sicherheitsstandards entspricht. Wir können daher nicht garantieren, dass die Seite im Internet Explorer in vollem Umfang funktioniert. Nutze bitte Chrome oder Firefox.

Erstellt von Judge 

Inovio Pharma diskutieren

Inovio Pharma

WKN: A115GK / Symbol: INO / Name: Inovio Pharma / Aktie / Biotechnologie & medizinische Forschung / Small Cap /

0,53 €
-2,24 %

Buy Inovio Pharma

Buy Inovio Pharma

Buy Inovio Pharma

Sell Inovio Pharma

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for INO provided by MarketBeat

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for INO provided by MarketBeat

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for INO provided by MarketBeat

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for INO provided by MarketBeat

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Ratings data for INO provided by MarketBeat

Einschätzung Buy
Rendite (%) -
Kursziel 3,68
Veränderung
Endet am 25.01.25

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was upgraded by analysts at Oppenheimer Holdings Inc. from a "market perform" rating to an "outperform" rating. They now have a $4.00 price target on the stock.
Ratings data for INO provided by MarketBeat

Inovio Pharmaceuticals, Inc. (NASDAQ: INO) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Ratings data for INO provided by MarketBeat